Culinary plants and their potential impact on metabolic overload

Annals of the New York Academy of Sciences

Volumn 1229, Issue 1, 2011, Pages 133-139

  Kim, Ji Yeon ^a   Kwon, Oran ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Culinary plants; Metabolic overload; Multicomponents; Multitargets

Indexed keywords

PHENOL DERIVATIVE; POLYPHENOL; SULFUR; TERPENE; VANILLIC ACID;

ADIPOCYTE; ARTICLE; CULINARY PLANT; DISEASE SEVERITY; HUMAN; INFLAMMATION; LIPOTOXICITY; MEDICAL RESEARCH; METABOLISM; NONHUMAN; OBESITY; PLANT; POSTPRANDIAL STATE;

EID: 79960753769     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06090.x     Document Type: Article

References (48)

1. Low Dog, T. 2006. A reason to season: the therapeutic benefits of spices and culinary herbs. Explore (NY). 2: 446-449.
2. Lampe, J.W. 2003. Spicing up a vegetarian diet: chemopreventive effects of phytochemicals. Am. J. Clin. Nutr. 78: 579S-583S.
3. Raskin, I. et al 2002. Plants and human health in the twenty-first century. Trends Biotechnol. 20: 522-531.
4. Holst, B. & G. Williamson 2008. Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants. Curr. Opin. Biotechnol. 19: 73-82.
5. Mallavadhani, U.V. et al 2003. Antifeedant activity of some pentacyclic triterpene acids and their fatty acid ester analogues. J. Agric. Food Chem. 51: 1952-1955.
6. Demmig-Adams, B., A.M. Gilmore & W.W. Adams 1996. Carotenoids 3: in vivo function of carotenoids in higher plants. FASEB J. 10: 403-412.
7. Yang, R.Y., S. Lin & G. Kuo 2008. Content and distribution of flavonoids among 91 edible plant species. Asia Pac. J. Clin. Nutr. 17(Suppl 1): 275-279.
8. Kaefer, C.M. & J.A. Milner 2008. The role of herbs and spices in cancer prevention. J. Nutr. Biochem. 19: 347-361.
9. Kris-Etherton, P.M. et al 2004. Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Annu. Rev. Nutr. 24: 511-538.
10. Most, M.M. 2004. Estimated phytochemical content of the dietary approaches to stop hypertension (DASH) diet is higher than in the Control Study Diet. J. Am. Diet Assoc. 104: 1725-1727.
11. Mennen, L.I. et al 2004. Consumption of foods rich in flavonoids is related to a decreased cardiovascular risk in apparently healthy French women. J. Nutr. 134: 923-926.
12. Burton-Freeman, B. 2010. Postprandial metabolic events and fruit-derived phenolics: a review of the science. Br. J. Nutr. 104(Suppl 3): S1-S14.
13. Nappo, F. et al 2002. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J. Am. Coll. Cardiol. 39: 1145-1150.
14. Sies, H., W. Stahl & A. Sevanian 2005. Nutritional, dietary and postprandial oxidative stress. J. Nutr. 135: 969-972.
15. Ursini, F., et al 1998. Postprandial plasma lipid hydroperoxides: a possible link between diet and atherosclerosis. Free Radic. Biol. Med. 25: 250-252.
16. Alipour, A. et al 2007. Postprandial inflammation and endothelial dysfuction. Biochem. Soc. Trans. 35: 466-469.
17. Quon, M.J. et al 1994. Insulin receptor substrate 1 mediates the stimulatory effect of insulin on GLUT4 translocation in transfected rat adipose cells. J. Biol. Chem. 269: 27920-27924.
18. Foufelle, F. & P. Ferré 2002. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem. J. 366: 377-391.
19. Unger, R.H. 2003. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol. Metab. 14: 398-403.
20. Guilherme, A. et al 2008. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9: 367-377.
21. Minokoshi, Y. & B.B. Kahn 2003. Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle. Biochem. Soc. Trans. 31: 196-201.
22. Monteiro, R. & I. Azevedo 2010. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. Art. ID 289645.
23. Sartipy, P. & D.J. Loskutoff 2003. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 100: 7265-7270.
24. Feinstein, R. et al 1993. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem. 268: 26055-26058.
25. Hotamisligil, G.S., N.S. Shargill & B.M. Spiegelman 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
26. Parhofer, K.G. & P.H. Barrett 2006. Thematic review series: patient-oriented research. What we have learned about VLDL and LDL metabolism from human kinetics studies. J. Lipid Res. 47: 1620-1630.
27. Laclaustra, M., D. Corella & J.M. Ordovas 2007. Metabolic syndrome pathophysiology: the role of adipose tissue. Nutr. Metab. Cardiovasc. Dis. 17: 125-139.
28. Sethi, J.K. & A.J. Vidal-Puig 2007. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J. Lipid Res. 48: 1253-1262.
29. Manach, C. et al 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81: 230S-242S.
30. Kwon, O. et al 2007. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J. 21: 366-377.
31. Yavropoulou, M.P. & J.G. Yovos 2010. Central regulation of glucose-dependent insulinotropic polypeptide secretion. Vitam. Horm. 84: 185-201.
32. Yuan, J.P., J.H. Wang & X. Liu 2007. Metabolism of dietary soy isoflavones to equol by human intestinal microflora-implications for health. Mol. Nutr. Food Res. 51: 765-781.
33. Graham, A. 2009. Curcumin adds spice to the debate: lipid metabolism in liver disease. Br. J. Pharmacol. 157: 1352-1353.
34. Woo, H.M. et al 2007. Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sci. 80: 926-931.
35. Balogun, E. et al 2003. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J. 371: 887-895.
36. Lee, Y.K. et al 2009. Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells. J. Agric. Food Chem. 57: 305-310.
37. Shehzad, A. et al 2011. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur. J. Nutr. 50: 151-161.
38. Karalis, K.P. et al 2009. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J. 276: 5747-5754.
39. Cordell, G.A. 2000. Biodiversity and drug discovery-a symbiotic relationship. Phytochemistry. 55: 463-480.
40. Ribnicky, D.M. et al 2008. Evaluation of botanicals for improving human health. Am. J. Clin. Nutr. 87: 472S-475S.
41. Schmidt, B.M. et al 2007. Revisiting the ancient concept of botanical therapeutics. Nat. Chem. Biol. 3: 360-366.
42. Barnes, S. et al 2008. Technologies and experimental approaches at the National Institutes of Health Botanical Research Centers. Am. J. Clin. Nutr. 87: 476S-480S.
43. Heymsfield, S.B. et al 1998. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA 280: 1596-1600.
44. AHPA Botanical Extracts Committee. 2003. Standardization of Botanical Products. Silverspring, MD American Herbal Products Association.
45. Jeffery, E. 2005. Component interactions for efficacy of functional foods. J. Nutr. 135: 1223-1225.
46. Morré, D.J. et al 2003. Tea catechin synergies in inhibition of cancer cell proliferation and of a cancer specific cell surface oxidase (ECTO-NOX). Pharmacol. Toxicol. 92: 234-241.
47. Csermely, P., V. Agoston & S. Pongor 2005. The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol. Sci. 26: 178-182.
48. Rogawski, M.A. 2000. Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents-toward an understanding of their favorable tolerability. Amino Acids 19: 133-149.